Medical Innovation Acceleration Act of 2025
In committeeWhat this bill is intended to do
Medical Innovation Acceleration Act of 2025 This bill exempts noninvasive diagnostic devices from the regulatory authority of the Food and Drug Administration. The bill defines noninvasive diagnostic device as one that does not penetrate the skin or any other membrane of the body, is not inserted or implanted into the body, causes no more than ephemeral compression or temperature changes to in situ bodily tissues, and does not subject bodily tissues to ionizing radiation.
Latest action
Jan 3, 2025Referred to the House Committee on Energy and Commerce.
No grade provided. The Quiet Ledger grades only on a bill's full statutory text, which Congress.gov hasn't published for this bill yet. PIN re-checks automatically and grades it the moment the text appears.